NTV Asset Management LLC Has $460,000 Position in Becton, Dickinson and Company $BDX

NTV Asset Management LLC lessened its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 17.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,672 shares of the medical instruments supplier’s stock after selling 566 shares during the quarter. NTV Asset Management LLC’s holdings in Becton, Dickinson and Company were worth $460,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Franklin Street Advisors Inc. NC acquired a new position in shares of Becton, Dickinson and Company in the second quarter valued at approximately $244,000. Keystone Financial Group Inc. boosted its stake in Becton, Dickinson and Company by 94.7% in the 2nd quarter. Keystone Financial Group Inc. now owns 623 shares of the medical instruments supplier’s stock valued at $112,000 after purchasing an additional 303 shares during the period. Ascent Group LLC grew its holdings in Becton, Dickinson and Company by 23.5% in the 2nd quarter. Ascent Group LLC now owns 3,686 shares of the medical instruments supplier’s stock valued at $635,000 after buying an additional 702 shares in the last quarter. Phraction Management LLC lifted its holdings in shares of Becton, Dickinson and Company by 1.5% during the second quarter. Phraction Management LLC now owns 50,201 shares of the medical instruments supplier’s stock worth $8,647,000 after buying an additional 733 shares in the last quarter. Finally, Ameritas Advisory Services LLC acquired a new stake in shares of Becton, Dickinson and Company during the second quarter worth $40,000. 86.97% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on BDX. Wall Street Zen raised shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Argus increased their price target on Becton, Dickinson and Company from $220.00 to $230.00 in a research report on Monday, September 15th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Becton, Dickinson and Company in a report on Saturday, September 27th. Piper Sandler reiterated a “neutral” rating and set a $200.00 target price (up from $185.00) on shares of Becton, Dickinson and Company in a research report on Friday, August 8th. Finally, Morgan Stanley raised their price target on Becton, Dickinson and Company from $196.00 to $197.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Three equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Becton, Dickinson and Company currently has an average rating of “Hold” and a consensus price target of $205.40.

Insider Buying and Selling

In related news, EVP Michael David Garrison sold 1,185 shares of the business’s stock in a transaction on Friday, July 18th. The stock was sold at an average price of $180.29, for a total transaction of $213,643.65. Following the sale, the executive vice president owned 4,887 shares in the company, valued at $881,077.23. The trade was a 19.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Claire Fraser sold 917 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $187.50, for a total value of $171,937.50. Following the completion of the transaction, the director owned 22,226 shares of the company’s stock, valued at $4,167,375. This represents a 3.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 3,023 shares of company stock worth $562,036 in the last 90 days. Company insiders own 0.36% of the company’s stock.

Becton, Dickinson and Company Trading Up 1.1%

Shares of BDX opened at $193.67 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.62 and a current ratio of 1.10. Becton, Dickinson and Company has a 52-week low of $163.33 and a 52-week high of $251.99. The firm has a market cap of $55.51 billion, a price-to-earnings ratio of 34.83, a PEG ratio of 1.51 and a beta of 0.25. The business’s fifty day moving average is $189.03 and its 200-day moving average is $187.38.

Becton, Dickinson and Company (NYSE:BDX) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.28. The business had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.50 billion. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%.Becton, Dickinson and Company’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $3.50 earnings per share. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. Equities analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Monday, September 8th were paid a $1.04 dividend. The ex-dividend date of this dividend was Monday, September 8th. This represents a $4.16 annualized dividend and a yield of 2.1%. Becton, Dickinson and Company’s dividend payout ratio is presently 74.82%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.